Prevalence, lifecourse and disability in social phobia

Author： Judd L.L.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 224-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MAOIs in social phobia

By Katschnig H.   Berger P.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 207-207

Elsevier

Access to resources Recommend Favorite

Impaired QOL with social phobia

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 290, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Basic and clinical aspects of social phobia

By den Boer J.A.   van Vliet I.M.   Westenberg H.G.M.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 225-226

Elsevier

Access to resources Recommend Favorite

Interaction of drugs and psychotherapy in social phobia

By Katschnig H.   Sachs G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 227-227

Elsevier

Access to resources Recommend Favorite

WPA educational programme on social phobia

By e Silva J.A.C.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 225-225

Elsevier

Access to resources Recommend Favorite